Lannett Company, Inc. (LCI) Names James Maher to Board of Directors
6/3/2013 7:56:38 AM
More...
|
Lannett Company, Inc. (LCI) Reports Record Fiscal 2013 Third Quarter Financial Results
5/9/2013 8:11:24 AM
More...
|
Lannett Company, Inc. (LCI) Announces Preliminary Fiscal 2013 Third Quarter Net Sales of $39 Million, Earnings Per Share Between $0.12 and $0.14
5/1/2013 7:41:28 AM
More...
|
Lannett Company, Inc. (LCI) to Present at Needham’s 12th Annual Healthcare Conference
4/23/2013 6:55:04 AM
More...
|
Lannett Company, Inc. (LCI) to Present at 25th Annual Roth Conference March 18
3/13/2013 6:38:34 AM
More...
|
Lannett Company, Inc. (LCI) Reports Strong Financial Results for Fiscal 2013 Second Quarter
2/8/2013 6:53:44 AM
More...
|
Lannett Company, Inc. (LCI) Receives FDA Approval for Butalbital, Acetaminophen and Caffeine Tablets USP, 50mg/325mg/40mg
9/14/2012 9:06:44 AM
More...
|
Lannett Company, Inc. (LCI) to Report Fiscal 2012 Fourth-Quarter, Full-Year Financial Results and Host Conference Call on Thursday, September 6
8/29/2012 10:12:00 AM
More...
|
Lannett Company, Inc. (LCI) Adds Paul Taveira to Board of Directors
5/11/2012 10:38:48 AM
More...
|
Lannett Company, Inc. (LCI) Reports Fiscal 2012 Third Quarter Financial Results
5/9/2012 10:51:04 AM
More...
|
|